drugset / Trial / NCT02571140
A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) Formulations in Healthy Subjects
Non-randomizedCrossoverOpen-labelTreatment
Summary
This study will have one stage consisting of multiple treatment visits. The study is designed to assess the safety and bioavailability of Entera's oral PTH(1 - 34) in adult male healthy volunteers in various formulation. The study is also designed to assess the reproducibility of pharmacokinetic profiles with various formulations.
Timeline
- Start
- 2013-10
- Primary completion
- 2017-08
- Completion
- 2017-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Teriparatide | Protein / enzyme biologic | — | Subcutaneous |
| Subject | Teriparatide | Protein / enzyme biologic | — | Oral |
Indications
No indication recorded.